• Pancreatic Cancer Testing Model Connects to Patient Populations

    Clinical Research News | Genialis and Inventia Life Science yesterday announced a collaboration to improve how new treatments for pancreatic cancer are tested and the patients most likely to benefit are enrolled in trials. The companies will combine Genialis' AI-powered patient insights with Inventia's RASTRUM 3D cell model platform to build human-relevant models of pancreatic ductal adenocarcinoma (PDAC) that correspond to the tumor biology of identifiable patient populations.

    Sep 24, 2026

  • Condor Launches Clinical Trial Finance Agent

    Clinical Research News | Last week, Condor launched a new clinical finance agent that gives R&D teams the "why" behind variances, runs full what-if scenario planning, and then builds the resulting model directly in Condor. It's part of a team of agents built on Condor's clinical and financial ontology and knowledge graph.

    Sep 22, 2026

  • Mayo Clinic, Thermo Fisher Scientific launch Precure, LLC

    Clinical Research News | This week Mayo Clinic announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific. Precure will create one of the world’s leading biomedical datasets by integrating proteomic, genomic, and longitudinal clinical data to help researchers identify early biological signals of disease and provide a foundation for new discoveries in disease biology, diagnostics and therapeutics.

    Sep 18, 2026

  • If We Were Designing Clinical Research Today, Would We Still Separate Source Documentation from Data Capture?

    Clinical Research News | Clinical research has never been only about generating evidence that a therapy is safe or effective. It is equally about generating confidence in the evidence itself. Every observation, every assessment, every protocol deviation, every adverse event, every laboratory result, and every conclusion must be supported by documentation that can withstand scrutiny. We work in a profession built on verification. “Trust but verify” is woven into our quality systems. “If it wasn't documented, it wasn't done” is probably the most recognized sentence in our field.

    Sep 16, 2026

  • The Adherence Imperative: Clinical Operations and Patient Centricity

    Clinical Research News | Participant adherence is a leading indicator of trial health. Adherence reflects patient centricity as a measure of how effectively a clinical trial has removed barriers, supported participants throughout the study journey and enabled sites to deliver a high-quality participant experience. As participant experiences improve, usually so does adherence, especially considering that approximately half of all dropouts in phases 2-3 come down to participant choice rather than adverse reactions or study staff decisions.

    Sep 11, 2026

  • Global Effort to Overhaul Regulatory Framework for AI Medical Devices

    Clinical Research News | Data routinely captured to track health and measure wellness do not reflect ground truth, as is well known in the field of medical informatics. That imperfect healthcare data is nonetheless being used to train artificial intelligence (AI) models powering devices used in patient care, often having never been evaluated on their clinical effectiveness.

    Sep 8, 2026

  • The Scope of Things: Source Preparation Emerges as a Clinical Trial Startup Bottleneck

    Clinical Research News | Clinical trial startup delays are often attributed to budgets, contracts, and regulatory review, but a less visible bottleneck may occur at the investigative site level: source preparation. During the latest episode of The Scope of Things, Ken Getz, executive director of the Tufts Center for the Study of Drug Development, and Rick Ward, chief commercial officer at CRIO, discussed their companies’ collaboration exploring how preparing source documents delays getting the first patient in and slows enrollment.

    Sep 3, 2026

  • FDA's Real-Time Clinical Trials Initiative Takes Shape: What Near-Live Data Sharing Means for Sponsors and Operations

    Clinical Research News | The FDA's Real-Time Clinical Trials (RTCT) initiative is testing whether earlier access to selected clinical trial data can improve regulatory oversight by allowing reviewers to observe selected safety and efficacy signals while studies remain underway. Under the proof-of-concept pilot announced in April, participating sponsors share agreed-upon data elements rather than giving FDA reviewers unrestricted access to complete trial databases.

    Sep 1, 2026

  • Real-Time Clinical Trials Need a Human Exception Log

    Clinical Research News | Clinical research is getting faster. The FDA’s Operation TrialBlazer is explicitly aimed at accelerating and modernizing clinical development, while the agency has also been building toward real-time clinical trials. Faster signal flow is a meaningful advance. It can reduce the delay between what happens in a trial and what regulators or sponsors can see. But it also changes the human work around the data.

    Aug 28, 2026

  • Follow the Money: Bioanalysis Platform, Limbal Stem Cell Deficiency, Bispecific Antibody-Drug Conjugates

    Clinical Research News | Expedition Therapeutics advances its lead COPD treatment into phase 2; Ratio Therapeutics continues a clinical study of a targeted radiotherapeutic for advanced sarcomas; Abcuro prepares to launch a registration-enabling study for inclusion body myositis; and more.

    Aug 26, 2026

  • Baylor College to Open Xenoliver Transplant Center, Imperial College London, ProAxsis Collaborate, NORD Announced Three New Additions

    Clinical Research News | Owkin announced a data collaboration with Kognitic; TrialAssure’s ANONYMIZE platform has been selected by the European Medicines Agency as an official anonymization tool; The Stein Institute for Research on Aging at the University of California San Diego shall serve as the Central Laboratory and Biorepository for the XPRIZE Healthspan Competition; and more.

    Aug 25, 2026

  • MD Anderson: Immune System Provides Biological Blueprint for Treating Cancer-Related Depression with Psychedelics

    Clinical Research News | Since the brain and body are inexorably connected and seem to modulate each other, it follows that the best way to help cancer patients suffering from depression is to view the condition holistically based on their systemic and brain biology and not just their lived experience. To that end, psychedelics like ketamine and psilocybin are actively entering the treatment paradigm.

    Aug 19, 2026

  • DIOSynVax Advances Broadly Protective Vaccine Platform with Phase 1 Proof of Concept

    Clinical Research News | Digital Immune-Optimized Synthetic vaccines (DIOSynVax) is betting that the future of vaccination lies not in chasing individual viral variants, but in designing broadly protective vaccines that target entire virus families. The University of Cambridge spinout is using artificial intelligence (AI), genomics, synthetic biology, and immunology to create vaccine antigens that could be delivered through a range of existing vaccine platforms, with early clinical data supporting the concept.

    Aug 18, 2026

  • Management of Co-Occurring Conditions of Down Syndrome Becoming More Personalized

    Clinical Research News | Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person.

    Aug 13, 2026

  • Blood Biomarker Panel May Enable Earlier ALS Prevention Trials

    Clinical Research News | Investigators at the University of Miami Miller School of Medicine reported that a 19-protein blood biomarker panel, which includes neurofilament light chain (NfL), accurately predicted the transition from presymptomatic disease to clinical amyotrophic lateral sclerosis (ALS), known as phenoconversion, across timeframes ranging from six months to five years.

    Aug 12, 2026

  • Primary Care Research Alliance ‘Flips the Script’ on Site Feasibility

    Clinical Research News | In the U.K., adversity has brought together 180 clinical trial sites—mostly GP (general practitioner) practices but also community health trusts, hospices, and home care providers—to realize that they have more to gain as collaborators than competitors. The mindset shift prompted the formation of the Primary Care Research Alliance (PCRA), which in the space of 18 months has grown from a core group of 12 practices with 250,000 patients to a network representing 8.5 million and counting.

    Aug 11, 2026

  • The Scope of Things: Chinese Drug Developers Look Toward Global Market

    Clinical Research News | In the most recent episode of The Scope of Things podcast, Daphne Smyth, head of global regulatory programs at Veristat, joins the conversation to relay her three days at BioChina 2026 in Suzhou and what the North American and European markets can expect from Chinese drug development.

    Aug 6, 2026

  • Vaccine ‘Intercepts’ Pancreatic Cancer in High-Risk Populations

    Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.

    Aug 4, 2026

  • Fresh Insights on What Helps Patient Recovery in the ICU

    Clinical Research News | The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit (ICU) is both safe and beneficial. Surprisingly, also giving them extra protein—a strategy used successfully with frail and elderly patients—doesn’t appear to have any additive benefit.

    Jul 30, 2026

  • Follow the Money: Metastatic Prostate Cancer, Once-Weekly GLP-1 Patch, Molecule Arts Platform

    Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.

    Jul 29, 2026